1
|
Pinto EC, Dolzan MD, Cabral LM, Armstrong DW, de Sousa VP. Topiramate: A Review of Analytical Approaches for the Drug Substance, Its Impurities and Pharmaceutical Formulations. J Chromatogr Sci 2015; 54:280-90. [PMID: 26276847 DOI: 10.1093/chromsci/bmv120] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2015] [Indexed: 11/14/2022]
Abstract
An important step during the development of high-performance liquid chromatography (HPLC) methods for quantitative analysis of drugs is choosing the appropriate detector. High sensitivity, reproducibility, stability, wide linear range, compatibility with gradient elution, non-destructive detection of the analyte and response unaffected by changes in the temperature/flow are some of the ideal characteristics of a universal HPLC detector. Topiramate is an anticonvulsant drug mainly used for the treatment of different types of seizures and prophylactic treatment of migraine. Different analytical approaches to quantify topiramate by HPLC have been described because of the lack of chromophoric moieties on its structure, such as derivatization with fluorescent moieties and UV-absorbing moieties, conductivity detection, evaporative light scattering detection, refractive index detection, chemiluminescent nitrogen detection and MS detection. Some methods for the determination of topiramate by capillary electrophoresis and gas chromatography have also been published. This systematic review provides a description of the main analytical methods presented in the literature to analyze topiramate in the drug substance and in pharmaceutical formulations. Each of these methods is briefly discussed, especially considering the detector used with HPLC. In addition, this article presents a review of the data available regarding topiramate stability, degradation products and impurities.
Collapse
Affiliation(s)
- Eduardo Costa Pinto
- Department of Pharmaceutics, Faculty of Pharmacy, Federal University of Rio de Janeiro, Av. Carlos Chagas Filho, 373, CCS, Bss, sala 15, Rio de Janeiro 21941-902, Brazil Department of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX, USA
| | - Maressa Danielli Dolzan
- Department of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX, USA Department of Chemistry, Federal University of Santa Catarina, Florianopolis, Santa Catarina, Brazil
| | - Lucio Mendes Cabral
- Department of Pharmaceutics, Faculty of Pharmacy, Federal University of Rio de Janeiro, Av. Carlos Chagas Filho, 373, CCS, Bss, sala 15, Rio de Janeiro 21941-902, Brazil
| | - Daniel W Armstrong
- Department of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX, USA
| | - Valéria Pereira de Sousa
- Department of Pharmaceutics, Faculty of Pharmacy, Federal University of Rio de Janeiro, Av. Carlos Chagas Filho, 373, CCS, Bss, sala 15, Rio de Janeiro 21941-902, Brazil
| |
Collapse
|
2
|
Wolfender JL, Marti G, Thomas A, Bertrand S. Current approaches and challenges for the metabolite profiling of complex natural extracts. J Chromatogr A 2015; 1382:136-64. [DOI: 10.1016/j.chroma.2014.10.091] [Citation(s) in RCA: 352] [Impact Index Per Article: 39.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2014] [Revised: 10/23/2014] [Accepted: 10/26/2014] [Indexed: 12/11/2022]
|
3
|
Rogers LA, Crews KE, Long SG, Patterson KM, McCune JE. Evaluation of Chromatographic Methods for Drug Products Containing Polar and Non-Polar Molecules Using Reversed Phase, Hydrophilic Interaction, and Ion Exchange Chromatography. J LIQ CHROMATOGR R T 2009. [DOI: 10.1080/10826070903163057] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- Lance A. Rogers
- a Pharmaceutical Development, GlaxoSmithKline , RTP, North Carolina, USA
| | - Karen E. Crews
- a Pharmaceutical Development, GlaxoSmithKline , RTP, North Carolina, USA
| | - Susan G. Long
- a Pharmaceutical Development, GlaxoSmithKline , RTP, North Carolina, USA
| | | | - John E. McCune
- a Pharmaceutical Development, GlaxoSmithKline , RTP, North Carolina, USA
| |
Collapse
|
5
|
Lee H. Pharmaceutical Applications of Liquid Chromatography Coupled with Mass Spectrometry (LC/MS). J LIQ CHROMATOGR R T 2007. [DOI: 10.1081/jlc-200053022] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Affiliation(s)
- Heewon Lee
- a Boehringer Ingelheim Pharmaceuticals, Inc. , Ridgefield, Connecticut, USA
| |
Collapse
|